Company profile
Brink Therapeutics
Unlocking in vivo cell therapy with the next generation of gene editing technology
- Industry
- Biotechnology Research
- Employees
- 12
- Headquarters
- Paris, Île-de-France
- Founded
- 2024
- LinkedIn followers
- 2,173
- Office locations
- 1
Brink Therapeutics company summary
Brink Therapeutics is a company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, founded in 2024. On LinkedIn the company has around 12 employees and 2,173 followers.
What technology does Brink Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Brink Therapeutics
Brink Therapeutics is developing next-generation recombinases — ultra-precise and efficient enzymes that surpass CRISPR-Cas9. We aim to revolutionize Cell and Gene therapies, enabling large-scale production to treat cancer, genetic disorders, and other diseases.
Where is Brink Therapeutics located?
Brink Therapeutics lists 1 location.
Compare companies similar to Brink Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Brink Therapeutics brinktx.com | Biotechnology Research | 12 | 2024 | Paris, Île-de-France |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Brink Therapeutics
What does Brink Therapeutics do?
Brink Therapeutics is developing next-generation recombinases — ultra-precise and efficient enzymes that surpass CRISPR-Cas9. We aim to revolutionize Cell and Gene therapies, enabling large-scale production to treat cancer, genetic disorders, and other diseases.
How many employees does Brink Therapeutics have?
Brink Therapeutics has around 12 employees on LinkedIn.
Where is Brink Therapeutics headquartered?
Brink Therapeutics is headquartered in Paris, Île-de-France.
When was Brink Therapeutics founded?
Brink Therapeutics was founded in 2024.
Build a lead list from companies like Brink Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.